ZA902593B - The use of liposomes for the delivery of therapeutic agents to wounds,cuts and abrasions - Google Patents

The use of liposomes for the delivery of therapeutic agents to wounds,cuts and abrasions

Info

Publication number
ZA902593B
ZA902593B ZA902593A ZA902593A ZA902593B ZA 902593 B ZA902593 B ZA 902593B ZA 902593 A ZA902593 A ZA 902593A ZA 902593 A ZA902593 A ZA 902593A ZA 902593 B ZA902593 B ZA 902593B
Authority
ZA
South Africa
Prior art keywords
abrasions
wounds
liposomes
cuts
delivery
Prior art date
Application number
ZA902593A
Inventor
Jack Michael Shaw
Michael Shaw Jack
Diana Maria Cordova
Maria Cordova Diana
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of ZA902593B publication Critical patent/ZA902593B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA902593A 1989-04-04 1990-04-04 The use of liposomes for the delivery of therapeutic agents to wounds,cuts and abrasions ZA902593B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33316489A 1989-04-04 1989-04-04

Publications (1)

Publication Number Publication Date
ZA902593B true ZA902593B (en) 1991-01-30

Family

ID=23301595

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA902593A ZA902593B (en) 1989-04-04 1990-04-04 The use of liposomes for the delivery of therapeutic agents to wounds,cuts and abrasions

Country Status (8)

Country Link
EP (1) EP0465588A4 (en)
JP (1) JPH04505319A (en)
KR (1) KR920700691A (en)
AU (1) AU633078B2 (en)
CA (1) CA2013770A1 (en)
IL (1) IL93996A0 (en)
WO (1) WO1990011781A1 (en)
ZA (1) ZA902593B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012808A1 (en) * 1990-02-22 1991-09-05 Macnaught Pty Limited Artificial tears
IT1240683B (en) * 1990-04-26 1993-12-17 Zambon Spa PHARMACEUTICAL COMPOSITION CONTAINING EGF
DE9312509U1 (en) * 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Preparations for external administration of antiseptic and / or wound healing promoting agents
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
US5589189A (en) * 1994-09-14 1996-12-31 Nexstar Pharmaceuticals, Inc. Liposome dispersion
US6043213A (en) * 1996-04-19 2000-03-28 R-Tech Ueno, Ltd. Drug composition comprising albumin as active ingredient
EP0982025A1 (en) * 1998-08-28 2000-03-01 Wilhelm Prof. Dr. Stoffel Synthetic tear fluid
EP1502586B1 (en) 1999-05-27 2006-09-27 Euro-Celtique S.A. Use of antiseptics in the manufacture of a pharmaceutical preparation for the prevention or treatment of inflammations in the interior of the human body
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
GB9919131D0 (en) * 1999-08-14 1999-10-13 Depuy Int Ltd Joint lubrication
WO2002074281A1 (en) * 2001-03-15 2002-09-26 Novartis Ag Ophthalmic compositions and use thereof
KR100915741B1 (en) * 2001-06-15 2009-09-04 코너스톤 파마슈티칼스 Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
DE10141018A1 (en) * 2001-08-22 2003-03-13 Eth Zuerich Eidgenoessische Te Use of negatively charged phospholipids and compositions comprising phospholipids for the treatment of the eye
DK1427394T3 (en) * 2001-09-18 2007-06-11 Vasogen Ireland Ltd Process for Accelerating Recovery from Trauma Using Apoptosis-Imitating Synthetic or Natural Devices
HK1077740A1 (en) 2001-12-20 2006-02-24 Ct Ingenieria Genetica Biotech Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation
CA2368656A1 (en) * 2002-01-21 2003-07-21 Vasogen Ireland Limited Receptor-ligand pairing for anti-inflammatory response
PL371626A1 (en) * 2002-01-21 2005-06-27 Vasogen Ireland Limited Pharmaceutically acceptable phosphate-glycerol carrying bodies
WO2004024123A1 (en) * 2002-09-16 2004-03-25 Vasogen Ireland Limited Accelerating recovery from trauma
AU2003275850A1 (en) * 2002-10-25 2004-05-13 Vasogen Ireland Limited Cyclooxygenase regulation with ps liposomes
AU2003275842A1 (en) * 2002-10-25 2004-05-13 Vasogen Ireland Limited Cyclooxygenase regulation with pg liposomes
WO2004082688A1 (en) * 2003-03-20 2004-09-30 Vasogen Ireland Limited Phosphatidylglycerol (pg) receptor agonists and antagonists
JP4669665B2 (en) * 2004-04-12 2011-04-13 正彦 阿部 Polycation-modified liposome having no cytotoxicity and method for producing the same
US8808715B1 (en) * 2004-11-23 2014-08-19 Georgia Regents Research Institute, Inc Methods and compositions for modulating keratinocyte function
AU2006294756A1 (en) * 2005-09-26 2007-04-05 Vasogen Ireland Limited Treatment of inflammation and vascular abnormalities of the eye
CU23411B6 (en) * 2005-12-29 2009-09-08 Ct Ingenieria Genetica Biotech TOPICAL USE OF THE EPIDERMAL GROWTH FACTOR IN LIPOSOMAS TO PREVENT AMBUTATION OF THE DIABETIC FOOT
CU23388B6 (en) 2006-01-31 2009-07-16 Ct Ingenieria Genetica Biotech PHARMACEUTICAL COMPOSITION OF MICROSPHERES TO PREVENT AMPUTATION OF THE DIABETIC FOOT
ES2284398B2 (en) * 2006-04-27 2008-12-16 Universidad Complutense De Madrid FORMULATION OF LIPOSOMAL VESICLES IN WATER SOLUTIONS WITH CHARACTERISTICS OF LAGRIMAL FILM.
KR100752990B1 (en) * 2006-08-02 2007-08-30 주식회사 대웅 Compositions for preventing or treating skin diseases comprising nanoliposomes and natural extracts
CA2717133C (en) 2008-02-29 2016-04-26 Nagoya Industrial Science Research Institute Liposome for delivery to posterior segment of eye and pharmaceutical composition for disease in posterior segment of eye
WO2009118658A2 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
EP2123258A1 (en) * 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomes for drug delivery
WO2010109330A2 (en) 2009-03-27 2010-09-30 University Of Oxford Cholesterol level lowering liposomes
US11052158B2 (en) * 2016-08-18 2021-07-06 Troy Bremer Delivery of urea to cells of the macula and retina using liposome constructs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540381B1 (en) * 1983-02-08 1986-05-30 Dior Sa Parfums Christian METHOD FOR STIMULATING CELL GROWTH; COSMETIC COMPOSITION, PHARMACEUTICAL AND COMPLEMENTARY COMPOSITION FOR CELL CULTURE MEDIUM APPLYING THIS PROCESS
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US4692454A (en) * 1986-02-03 1987-09-08 Warner-Lambert Company Opthalmic use of quinolone antibiotics
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
EP0316345A1 (en) * 1986-07-28 1989-05-24 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4752425A (en) * 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
US5064655A (en) * 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method

Also Published As

Publication number Publication date
JPH04505319A (en) 1992-09-17
IL93996A0 (en) 1991-01-31
KR920700691A (en) 1992-08-10
CA2013770A1 (en) 1990-10-04
WO1990011781A1 (en) 1990-10-18
AU5429790A (en) 1990-11-05
EP0465588A4 (en) 1992-06-03
EP0465588A1 (en) 1992-01-15
AU633078B2 (en) 1993-01-21

Similar Documents

Publication Publication Date Title
ZA902593B (en) The use of liposomes for the delivery of therapeutic agents to wounds,cuts and abrasions
HK1005985A1 (en) Combined use of hyaluronic acid and therapeutic agents to improve the therapeutic effect
NZ228564A (en) Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
EG18268A (en) Medicament for the treatment of inflammation of the eye
AU4778893A (en) System of drug delivery to the lymphatic tissues
EP0412350A3 (en) Renininhibitors, procedure for their preparation and use as medicaments
EP0249873A3 (en) Therapeutic agent for skin ulcers
GR3030150T3 (en) Use of Human Interferon-Beta 2A for the preparation of medicaments
EP0207614A3 (en) Use of benzopyran compounds in the treatment of incontinence
PT86205A (en) Process for the preparation of 3-]omega-(3,5-di-t-butil-4-hydroxyphenyl)-alkanoyl"pyrroles and their de-oxy analogs useful in therapy
AU590783B2 (en) Therapeutic agent for treating hematopoietic diseases
GR3036384T3 (en) Medicament form for the delivery of collagenase to wounds and process for the preparation thereof
IL115652A (en) Use of vWF or fragments thereof for the preparation of medicaments having an antidote effect to antithrombotic and/or fibrinolytic agents producing hemorrhages
IL107764A0 (en) Use of certain methanebisphosphonic acid derivatives in fracture healing
GR862249B (en) Dihydropyridin-2-hydroxyamine process for their preparation and their use as medicaments
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
GB2170403B (en) Medicament for treatment of asthma and preparation thereof
GB8911259D0 (en) Inhalation medicament
ZA855137B (en) Bandage for sustained delivery of drugs
AU3764689A (en) Use of local anaesthetic agents in the manufacture of preparations with wound healing effect
AU3406389A (en) Synergistic combinations of beta-mimetic compounds and PAF-antagonists and their use as therapeutic agents
NZ271496A (en) Treating hiv; use of azaspirane compounds to manufacture medicaments
ZA86365B (en) Use of sulphanyldihydropyridines as medicaments for the treatment of asthma
ZA905715B (en) 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthalenes,processes for their preparation and their use as medicaments
AU1778088A (en) Use of analgesic anti-inflammatory drugs in treating haemorrhoidal bleeding